One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Neurovascular Embolization Devices (Neurology) Market

Neurovascular Embolization Devices (Neurology) Market (Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, and Others; Treatment: Ischemic Stroke Solutions and Hemorrhagic Stroke Solutions; Indication: Brain Aneurysms, Arteriovenous Malformation (AVM), and Others; and End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027


Product Code : TMRHC00110849
Survey : Transparency Market Research
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5795 / Question Form
5 User USD8795 / Question Form
Enterprise User USD11795 / Question Form
Medtronic plc
Stryker Corporation
DePuy Synthes (Johnson & Johnson Services, Inc.)
B.Braun Melsungen AG
Penumbra, Inc.
Acandis GmbH
BALT EXTRUSION
Terumo Medical Corporation
Boston Scientific Corporation
Spartan Micro, Inc.

[Report Description]

Neurovascular Embolization Devices (Neurology) Market – Scope of the Report

TMR’s report on the global neurovascular embolization devices (neurology) market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global neurovascular embolization devices (neurology) market for the period of 2017–2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global neurovascular embolization devices (neurology) market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents, to understand the global neurovascular embolization devices (neurology) market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global neurovascular embolization devices (neurology) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global neurovascular embolization devices (neurology) market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global neurovascular embolization devices (neurology) market. The next section of the global neurovascular embolization devices (neurology) report highlights the USPs, which include the regulatory scenario, reimbursement scenario, key mergers & acquisitions, technological advancements, and key industry developments in the global neurovascular embolization devices (neurology) market.

The report delves into the competitive landscape of the global neurovascular embolization devices (neurology) market. Key players operating in the global neurovascular embolization devices (neurology) market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overviews, financial standings, recent developments, and SWOTs are some of the attributes of players in the global neurovascular embolization devices (neurology) market profiled in this report.

Key Questions Answered in the Neurovascular Embolization Devices (Neurology) Market Report

What are the major drivers, restraints, opportunities in the market?
What are the revenue share projections of key segments in the global neurovascular embolization devices (neurology) market for the forecast period?
Which segment is likely to lead the neurovascular embolization devices (neurology) market in terms of revenue by 2027?
How are mergers & acquisitions among players widening the scope of the neuroendovascular embolization devices (neurology) market?
What is the market position of different companies operating in the global neurovascular embolization devices (neurology) market?
Research Objectives and Research Approach

The comprehensive report on the global neurovascular embolization devices (neurology) market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the global neurovascular embolization devices (neurology) market. It is followed by a market introduction, market dynamics, and an overview of the global neurovascular embolization devices (neurology) market, which includes TMR’s analysis of the market drivers, restraints, and trends affecting the growth of the global neurovascular embolization devices (neurology) market. Furthermore, to understand the Y-o-Y trends of the neurovascular embolization devices (neurology) market, a Y-o-Y analysis with elaborated insights on the same have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to the readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Key Industry Developments

5.2. Regulatory Scenario

5.3. Reimbursement Scenario

5.4. Key Mergers & Acquisitions

5.5. Technological Advancements

6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product

6.1. Introduction & Definition

6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

6.2.1. Embolization Coils

6.2.2. Liquid Embolic Systems

6.2.3. Flow Diversion Stents

6.2.4. Aneurysm Clips

6.2.5. Others

6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product

7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment

7.1. Introduction & Definition

7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

7.2.1. Ischemic Stroke Solution

7.2.2. Hemorrhagic Stroke Solution

7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment

8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication

8.1. Introduction

8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

8.2.1. Brain Aneurysms

8.2.2. Arteriovenous Malformation (AVM)

8.2.3. Others

8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication

9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User

9.1. Introduction

9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

9.2.1. Hospitals

9.2.2. Ambulatory Surgery Centers

9.2.3. Specialty Clinics

9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User

10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region

10.1. Introduction

10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region

11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

11.1. Introduction

11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

11.2.1. Embolization Coils

11.2.2. Liquid Embolic Systems

11.2.3. Flow Diversion Stents

11.2.4. Aneurysm Clips

11.2.5. Others

11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

11.3.1. Ischemic Stroke Solution

11.3.2. Hemorrhagic Stroke Solution

11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

11.4.1. Brain Aneurysms

11.4.2. Arteriovenous Malformation (AVM)

11.4.3. Others

11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

11.5.1. Hospitals

11.5.2. Ambulatory Surgery Centers

11.5.3. Specialty Clinics

11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

11.7.1. By Product

11.7.2. By Treatment

11.7.3. By Indication

11.7.4. By End User

11.7.5. By Country/Sub-region

12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

12.1. Introduction

12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

12.2.1. Embolization Coils

12.2.2. Liquid Embolic Systems

12.2.3. Flow Diversion Stents

12.2.4. Aneurysm Clips

12.2.5. Others

12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

12.3.1. Ischemic Stroke Solution

12.3.2. Hemorrhagic Stroke Solution

12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

12.4.1. Brain Aneurysms

12.4.2. Arteriovenous Malformation (AVM)

12.4.3. Others

12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

12.5.1. Hospitals

12.5.2. Ambulatory Surgery Centers

12.5.3. Specialty Clinics

12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

12.7.1. By Product

12.7.2. By Treatment

12.7.3. By Indication

12.7.4. By End User

12.7.5. By Country/Sub-region

13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

13.1. Introduction

13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

13.2.1. Embolization Coils

13.2.2. Liquid Embolic Systems

13.2.3. Flow Diversion Stents

13.2.4. Aneurysm Clips

13.2.5. Others

13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

13.3.1. Ischemic Stroke Solution

13.3.2. Hemorrhagic Stroke Solution

13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

13.4.1. Brain Aneurysms

13.4.2. Arteriovenous Malformation (AVM)

13.4.3. Others

13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

13.5.1. Hospitals

13.5.2. Ambulatory Surgery Centers

13.5.3. Specialty Clinics

13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. Japan

13.6.2. China

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

13.7.1. By Product

13.7.2. By Treatment

13.7.3. By Indication

13.7.4. By End User

13.7.5. By Country/Sub-region

14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

14.1. Introduction

14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

14.2.1. Embolization Coils

14.2.2. Liquid Embolic Systems

14.2.3. Flow Diversion Stents

14.2.4. Aneurysm Clips

14.2.5. Others

14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

14.3.1. Ischemic Stroke Solution

14.3.2. Hemorrhagic Stroke Solution

14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

14.4.1. Brain Aneurysms

14.4.2. Arteriovenous Malformation (AVM)

14.4.3. Others

14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

14.5.1. Hospitals

14.5.2. Ambulatory Surgery Centers

14.5.3. Specialty Clinics

14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

14.7.1. By Product

14.7.2. By Treatment

14.7.3. By Indication

14.7.4. By End User

14.7.5. By Country/Sub-region

15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

15.1. Introduction

15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

15.2.1. Embolization Coils

15.2.2. Liquid Embolic Systems

15.2.3. Flow Diversion Stents

15.2.4. Aneurysm Clips

15.2.5. Others

15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

15.3.1. Ischemic Stroke Solution

15.3.2. Hemorrhagic Stroke Solution

15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

15.4.1. Brain Aneurysms

15.4.2. Arteriovenous Malformation (AVM)

15.4.3. Others

15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

15.5.1. Hospitals

15.5.2. Ambulatory Surgery Centers

15.5.3. Specialty Clinics

15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

15.7.1. By Product

15.7.2. By Treatment

15.7.3. By Indication

15.7.4. By End User

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)

16.2. Company Profiles

16.2.1. Medtronic plc

16.2.1.1. Company Description

16.2.1.2. Business Overview

16.2.1.3. Financial Overview

16.2.1.4. Strategic Overview

16.2.1.5. SWOT Analysis

16.2.2. Stryker Corporation

16.2.2.1. Company Description

16.2.2.2. Business Overview

16.2.2.3. Financial Overview

16.2.2.4. Strategic Overview

16.2.2.5. SWOT Analysis

16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)

16.2.3.1. Company Description

16.2.3.2. Business Overview

16.2.3.3. Financial Overview

16.2.3.4. Strategic Overview

16.2.3.5. SWOT Analysis

16.2.4. B.Braun Melsungen AG

16.2.4.1. Company Description

16.2.4.2. Business Overview

16.2.4.3. Financial Overview

16.2.4.4. Strategic Overview

16.2.4.5. SWOT Analysis

16.2.5. Penumbra, Inc.

16.2.5.1. Company Description

16.2.5.2. Business Overview

16.2.5.3. Financial Overview

16.2.5.4. Strategic Overview

16.2.5.5. SWOT Analysis

16.2.6. Acandis GmbH

16.2.6.1. Company Description

16.2.6.2. Business Overview

16.2.6.3. Financial Overview

16.2.6.4. Strategic Overview

16.2.6.5. SWOT Analysis

16.2.7. BALT EXTRUSION

16.2.7.1. Company Description

16.2.7.2. Business Overview

16.2.7.3. Financial Overview

16.2.7.4. Strategic Overview

16.2.7.5. SWOT Analysis

16.2.8. Terumo Medical Corporation

16.2.8.1. Company Description

16.2.8.2. Business Overview

16.2.8.3. Financial Overview

16.2.8.4. Strategic Overview

16.2.8.5. SWOT Analysis

16.2.9. Boston Scientific Corporation

16.2.9.1. Company Description

16.2.9.2. Business Overview

16.2.9.3. Financial Overview

16.2.9.4. Strategic Overview

16.2.9.5. SWOT Analysis

16.2.10. Spartan Micro, Inc.

16.2.10.1. Company Description

16.2.10.2. Business Overview

16.2.10.3. Financial Overview

16.2.10.4. Strategic Overview

16.2.10.5. SWOT Analysis

List of Tables



Table 01: Hospital Inpatient Billing and Payment Reimbursement Scenario

Table 02: Physician Billing and Payment for Reimbursement

Table 03: Key Mergers and Acquisitions

Table 04: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 05: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017–2027

Table 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 07: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 08: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 10: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 12: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 13: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 14: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 16: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 17: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 18: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 19: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 21: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 22: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 23: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 24: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 25: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 26: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 27: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 28: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 29: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 31: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 32: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 33: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

List of Figures



Figure 01: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Distribution (%), by Region, 2019 and 2027

Figure 02: Neurovascular Embolization Devices (Neurology) Market – Key Industry Developments

Figure 03: Market Drivers

Figure 04: Market Restraints

Figure 05: Key Opportunities

Figure 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, 2017–2027

Figure 07: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product (2018)

Figure 08: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment (2018)

Figure 09: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication (2018)

Figure 10: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User (2018)

Figure 11: Europe Regulatory Approval Process

Figure 12: Technological Advancements

Figure 13: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 14: Global Neurovascular Embolization Devices Neurology) Market Attractiveness, by Product, 2019–2027

Figure 15: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Embolization Coils, 2017–2027

Figure 16: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liquid Embolic Systems, 2017–2027

Figure 17: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Diversion Stents, 2017–2027

Figure 18: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aneurysm Clips, 2017–2027

Figure 19: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 20: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 21: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 22: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrhagic Stroke Solution, 2017–2027

Figure 23: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ischemic Stroke Solution, 2017–2027

Figure 24: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 25: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 26: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain Aneurysms, 2017–2027

Figure 27: Global Ne Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arteriovenous Malformations (AVMs), 2017–2027

Figure 28: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 29: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 30: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 31: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 32: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027

Figure 33: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027

Figure 34: Global Neurovascular Embolization Devices (Neurology) Market: Regional Outlook

Figure 35: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Region, 2018 and 2027

Figure 36: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Region, 2019–2027

Figure 37: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 38: North America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country, 2018 and 2027

Figure 39: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country, 2019–2027

Figure 40: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 41: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 42: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 43: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 44: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 45: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 46: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 47: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 48: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 49: Europe Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 50: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 51: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 52: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 53: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 54: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 55: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 56: Europe N Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 57: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 58: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 59: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 60: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 61: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 62: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 63: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 64: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 65: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 66: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 67: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 68: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 69: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 70: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 71: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 72: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 73: Latin Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 74: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 75: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 76: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 77: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 78: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 79: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 80: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 81: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 82: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 83: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 84: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 85: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 86: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 87: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 88: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 89: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 90: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 91: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 92: Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+